Operating Lease, Liability in USD of Nurix Therapeutics, Inc. from Q1 2022 to Q4 2024

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: Nurix Therapeutics, Inc. quarterly Operating Lease, Liability history and change rate from Q1 2022 to Q4 2024.
Nurix Therapeutics, Inc. Operating Lease, Liability for the quarter ending 30 Nov 2024 was $28.3M, a 7.55% decline year-over-year.

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Change (%)

Nurix Therapeutics, Inc. Quarterly Operating Lease, Liability (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2024	$28.3M	-$2.31M	-7.55%	30 Nov 2024	10-K	28 Jan 2025
Q4 2023	$30.6M	+$18.7M	+156%	30 Nov 2023	10-K	15 Feb 2024
Q4 2022	$12M			30 Nov 2022	10-K	09 Feb 2023
Q3 2022	$13.2M			31 Aug 2022	10-Q	06 Oct 2022
Q2 2022	$14.5M			31 May 2022	10-Q	07 Jul 2022
Q1 2022	$15.8M			28 Feb 2022	10-Q	08 Apr 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.